Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced it has received...
-
LONDON, April 21, 2026 (GLOBE NEWSWIRE) -- Quadrant, a subsidiary of Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW), has set a new benchmark following the success of its latest...
-
GRAND RAPIDS, Mich., April 21, 2026 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ: IBCP), the holding company of Independent Bank, a Michigan-based community bank, announced that today...
-
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the launch of the Royalty Pharma Translational Prize, which recognizes exceptional achievements in...
-
65 per cent of Canadian say dining out is an important part of their Mother’s Day celebration 1Nearly a quarter (23%) of moms said they would consider dining alone at a restaurant for part of their...
-
CEDAR RAPIDS, Iowa, April 21, 2026 (GLOBE NEWSWIRE) -- United Fire Group, Inc. (Nasdaq: UFCS) (UFG) announced today that its first quarter 2026 earnings results will be released after the market...
-
VANCOUVER, Columbia Británica, April 21, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), proveedor de soluciones tecnológicas especializado en drones...
-
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with...
-
PORTLAND, Maine, April 21, 2026 (GLOBE NEWSWIRE) -- Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based bank, announced today it will release its fiscal 2026 third quarter earnings results on...
-
Poster also to be presented on the Phase 2 data of silevertinib in recurrent EGFRm NSCLC patients Trial-in-progress poster to be presented on the randomized Phase 2 trial of silevertinib in patients...